Artigo
Ant colony optimization as a feature selection method in QSAR modeling of anti-HIV-1 activities of 3-(3,5-Dimethylbenzyl)uracil derivatives using MLR and SVM regression
Carregando...
Notas
Data
Orientadores
Editores
Coorientadores
Membros de banca
Título da Revista
ISSN da Revista
Título de Volume
Editor
Elsevier
Faculdade, Instituto ou Escola
Departamento
Programa de Pós-Graduação
Agência de fomento
Tipo de impacto
Áreas Temáticas da Extenção
Objetivos de Desenvolvimento Sustentável
Dados abertos
Resumo
Abstract
A quantitative structure-activity relationship (QSAR) modeling was carried out for the anti-HIV-1 activities of 3-(3,5-dimethylbenzyl)uracil derivatives. The ant colony optimization (ACO) strategy was used as a feature selection (descriptor selection) and model development method. Modeling of the relationship between selected molecular descriptors and pEC50 data was achieved by linear (multiple linear regression-MLR, and partial least squares regression-PLS) and nonlinear (support-vector machine regression; SVMR) methods. The QSAR models were validated by cross-validation, as well as through the prediction of activities of an external set of compounds. Both linear and nonlinear methods were found to be better than a PLS-based method using forward stepwise (FS) selection, resulting in accurate predictions, especially for the SVM regression. The squared correlation coefficients of experimental versus predicted activities for the test set obtained by MLR, PLS and SVMR models using ACO feature selection were 0.942, 0.945 and 0.991, respectively.
Descrição
Área de concentração
Agência de desenvolvimento
Palavra chave
Marca
Objetivo
Procedência
Impacto da pesquisa
Resumen
ISBN
DOI
Citação
GOODARZI, M.; FREITAS, M. P.; JENSEN, R. Ant colony optimization as a feature selection method in QSAR modeling of anti-HIV-1 activities of 3-(3,5-Dimethylbenzyl)uracil derivatives using MLR and SVM regression. Chemometrics and Intelligent Laboratory Systems, [S.l.], v. 98, n. 2, p. 123-129, Oct. 2009. DOI: 10.1016/j.chemolab.2009.05.005.
